Impurity reference standards
Pomalidomide impurities & reference standards
Characterised Pomalidomide impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
40reference materials
2isotope-labelled
COAHPLC · NMR · MS on request
Parent API: Pomalidomide WS
19171-19-8 · C13H11N3O4
1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)-5-aminoisoindoline
- CAS
- 191732-76-0
- Formula
- C13H11N3O4
- MW
- 273.24 g/mol
VQ-032417
2-(4-Amino-1,3-dioxoisoindolin-2-yl)pentanedioic Acid
- CAS
- 18658-36-1
- Formula
- C13H12N2O6
- MW
- 292.24 g/mol
VQ-041549
2-Amino-6-((1-amino-4-carboxy-1-oxobutan-2-yl)carbamoyl)benzoic Acid
- CAS
- 1795373-41-9
- Formula
- C13H15N3O6
- MW
- 309.27 g/mol
VQ-043262
4-Amino-2-(2,6-dioxopiperidin-3-yl)-5,6,7-trihydroxyisoindoline-1,3-dione
- CAS
- 1795373-44-2
- Formula
- C13H11N3O7
- MW
- 321.24 g/mol
VQ-043263
![4-Amino-2'-(2,6-dioxopiperidin-3-yl)-[2,4'-biisoindoline]-1,1',3,3'-tetraone chemical structure](/media/structures/TXARGULUZPGWEK-UHFFFAOYSA-N.svg)
4-Amino-2'-(2,6-dioxopiperidin-3-yl)-[2,4'-biisoindoline]-1,1',3,3'-tetraone
- CAS
- 1795373-54-4
- Formula
- C21H14N4O6
- MW
- 418.4 g/mol
VQ-027555
Pomalidomide Hydroxylamine Impurity (S-Isomer)
- CAS
- 497146-89-1
- Formula
- C13H11N3O5
- MW
- 289.24 g/mol
VQ-005573
![Pomalidomide Impurity RS-06 (Stage - (N-1)) [Alternate CAS number]](/media/pack/pomalidomide-impurity-rs-06-stage-n-1-alternate-cas-number.svg?v=3)
Pomalidomide Impurity RS-06 (Stage - (N-1)) [Alternate CAS number]
- CAS
- 918314-36-0
- Formula
- C13H11N3O7
- MW
- 321.24 g/mol
In stock
FAQs — Pomalidomide impurities
Which Pomalidomide impurities do you supply?
We list 40 Pomalidomide-related reference materials, including process impurities, degradation products, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Pomalidomide impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Pomalidomide impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Pomalidomide impurity standards
We reply within one business day with price, pack options, lead time and documentation.